v3.26.3
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Jun. 30, 2026
General and administrative costs $ 703,251 $ 86,377 $ 1,033,137
Loss from operations (703,251) (86,377) (1,033,137)
Other income:      
Interest earned on cash held in Trust Account 1,551,680   2,968,775
Total other income 1,551,680   2,968,775
Net income $ 848,429 $ (86,377) $ 1,935,638
Class B ordinary shares      
Other income:      
Basic weighted average shares outstanding (in shares) 6,500,000 [1] 5,000,000 [2] 6,475,138 [1]
Diluted weighted average shares outstanding (in shares) 6,500,000 5,000,000 [2] 6,500,000 [1]
Basic net income per ordinary share (in dollars per share) $ 0.04 $ (0.02) $ 0.08
Diluted net income per ordinary shares (in dollars per share) $ 0.04 $ (0.02) $ 0.08
Class A ordinary shares subject to possible redemption      
Other income:      
Basic weighted average shares outstanding (in shares) 17,250,000   16,678,177
Diluted weighted average shares outstanding (in shares) 17,250,000   16,678,177
Basic net income per ordinary share (in dollars per share) $ 0.04   $ 0.08
Diluted net income per ordinary shares (in dollars per share) $ 0.04   $ 0.08
[1] As of December 31, 2025, up to an aggregate of 750,000 Class B ordinary shares were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On January 7, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture (see Note 5).
[2] Excludes an aggregate of 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On January 7, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture (see Note 5).